Similar articles for PMID: 8632316

Year	Number of Results
1977	1
1983	1
1990	1
1992	1
1994	5
1995	13
1996	9
1997	12
1998	13
1999	13
2000	15
2001	12
2002	9
2003	14
2004	16
2005	12
2006	6
2007	7
2008	8
2009	5
2010	4
2011	1
2012	3
2013	2
2014	2
2015	1
2016	1
2018	4
2020	1
2021	3
2024	0

1

Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.

Sacaan AI, Menzaghi F, Dunlop JL, Correa LD, Whelan KT, Lloyd GK. Sacaan AI, et al. J Pharmacol Exp Ther. 1996 Feb;276(2):509-15. J Pharmacol Exp Ther. 1996. PMID: 8632316

2

Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.

Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI. Rao TS, et al. Brain Res. 2003 Nov 14;990(1-2):203-8. doi: 10.1016/s0006-8993(03)03532-7. Brain Res. 2003. PMID: 14568345

3

Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.

Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK. Sacaan AI, et al. J Pharmacol Exp Ther. 1997 Jan;280(1):373-83. J Pharmacol Exp Ther. 1997. PMID: 8996218

4

Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.

Cao YJ, Surowy CS, Puttfarcken PS. Cao YJ, et al. J Pharmacol Exp Ther. 2005 Mar;312(3):1298-304. doi: 10.1124/jpet.104.076794. Epub 2004 Nov 12. J Pharmacol Exp Ther. 2005. PMID: 15542623

5

Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.

Sacaan AI, Dunlop JL, Lloyd GK. Sacaan AI, et al. J Pharmacol Exp Ther. 1995 Jul;274(1):224-30. J Pharmacol Exp Ther. 1995. PMID: 7542334

6

Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.

Rousseau SJ, Jones IW, Pullar IA, Wonnacott S. Rousseau SJ, et al. Neuropharmacology. 2005 Jul;49(1):59-72. doi: 10.1016/j.neuropharm.2005.01.030. Epub 2005 Apr 21. Neuropharmacology. 2005. PMID: 15992581

7

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ, et al. Sullivan JP, et al. J Pharmacol Exp Ther. 1994 Nov;271(2):624-31. J Pharmacol Exp Ther. 1994. PMID: 7965777

8

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.

Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP. Donnelly-Roberts DL, et al. J Pharmacol Exp Ther. 1998 May;285(2):777-86. J Pharmacol Exp Ther. 1998. PMID: 9580626

9

Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats.

Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK. Menzaghi F, et al. J Pharmacol Exp Ther. 1997 Jan;280(1):384-92. J Pharmacol Exp Ther. 1997. PMID: 8996219

10

Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Clarke PB, Reuben M. Clarke PB, et al. Br J Pharmacol. 1996 Feb;117(4):595-606. doi: 10.1111/j.1476-5381.1996.tb15232.x. Br J Pharmacol. 1996. PMID: 8646402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year